Taken together these results demonstrate that the p66Shc-dependent decrease in intracellular ROS contributes to promote NF-κB activity in CLL cells, thereby enhancing the expression of the homing receptors CCR2, CXCR3 and CCR7. Here, NFKB1 is linked to B-cell chronic lymphocytic leukemia.